Total order in opportunistic networks

Opportunistic network applications are usually assumed to work only with unordered immutable messages, like photos, videos, or music files, while applications that depend on ordered or mutable messages, like chat or shared contents editing applications, are ignored. In this paper, we examine how total ordering can be achieved in an opportunistic network. By leveraging on existing dissemination and causal order algorithms, we propose a commutative replicated data type algorithm on the basis of Logoot for achieving total order without using tombstones in opportunistic networks where message delivery is not guaranteed by the routing layer. Our algorithm is designed to use the nature of the opportunistic network to reduce the metadata size compared to the original Logoot, and even to achieve in some cases higher hit rates compared to the dissemination algorithms when no order is enforced. Finally, we present the results of the experiments for the new algorithm by using an opportunistic network emulator, mobility traces, and Wikipedia pages.Peer ReviewedPostprint (author's final draft

Total order in opportunistic networks

Opportunistic network applications are usually assumed to work only with unordered immutable messages, like photos, videos, or music files, while applications that depend on ordered or mutable messages, like chat or shared contents editing applications, are ignored. In this paper, we examine how total ordering can be achieved in an opportunistic network. By leveraging on existing dissemination and causal order algorithms, we propose a commutative replicated data type algorithm on the basis of Logoot for achieving total order without using tombstones in opportunistic networks where message delivery is not guaranteed by the routing layer. Our algorithm is designed to use the nature of the opportunistic network to reduce the metadata size compared to the original Logoot, and even to achieve in some cases higher hit rates compared to the dissemination algorithms when no order is enforced. Finally, we present the results of the experiments for the new algorithm by using an opportunistic network emulator, mobility traces, and Wikipedia pages.Peer Reviewe

Total order in opportunistic networks

Opportunistic network applications are usually assumed to work only with unordered immutable messages, like photos, videos, or music files, while applications that depend on ordered or mutable messages, like chat or shared contents editing applications, are ignored. In this paper, we examine how total ordering can be achieved in an opportunistic network. By leveraging on existing dissemination and causal order algorithms, we propose a commutative replicated data type algorithm on the basis of Logoot for achieving total order without using tombstones in opportunistic networks where message delivery is not guaranteed by the routing layer. Our algorithm is designed to use the nature of the opportunistic network to reduce the metadata size compared to the original Logoot, and even to achieve in some cases higher hit rates compared to the dissemination algorithms when no order is enforced. Finally, we present the results of the experiments for the new algorithm by using an opportunistic network emulator, mobility traces, and Wikipedia pages

Rationale, design, and baseline characteristics in Evaluation of LIXisenatide in Acute Coronary Syndrome, a long-term cardiovascular end point trial of lixisenatide versus placebo

BACKGROUND: Cardiovascular (CV) disease is the leading cause of morbidity and mortality in patients with type 2 diabetes mellitus (T2DM). Furthermore, patients with T2DM and acute coronary syndrome (ACS) have a particularly high risk of CV events. The glucagon-like peptide 1 receptor agonist, lixisenatide, improves glycemia, but its effects on CV events have not been thoroughly evaluated. METHODS: ELIXA (www.clinicaltrials.gov no. NCT01147250) is a randomized, double-blind, placebo-controlled, parallel-group, multicenter study of lixisenatide in patients with T2DM and a recent ACS event. The primary aim is to evaluate the effects of lixisenatide on CV morbidity and mortality in a population at high CV risk. The primary efficacy end point is a composite of time to CV death, nonfatal myocardial infarction, nonfatal stroke, or hospitalization for unstable angina. Data are systematically collected for safety outcomes, including hypoglycemia, pancreatitis, and malignancy. RESULTS: Enrollment began in July 2010 and ended in August 2013; 6,068 patients from 49 countries were randomized. Of these, 69% are men and 75% are white; at baseline, the mean ± SD age was 60.3 ± 9.7 years, body mass index was 30.2 ± 5.7 kg/m(2), and duration of T2DM was 9.3 ± 8.2 years. The qualifying ACS was a myocardial infarction in 83% and unstable angina in 17%. The study will continue until the positive adjudication of the protocol-specified number of primary CV events. CONCLUSION: ELIXA will be the first trial to report the safety and efficacy of a glucagon-like peptide 1 receptor agonist in people with T2DM and high CV event risk